Aspirin Dosing in Pregnancy

Summary

The purpose of this study is assess platelet phenotypes based on aspirin dosing in pregnant patients at risk for the development preeclampsia who are taking 81mg twice a day aspirin. Blood samples will be collected approximately 4 weeks after initiation of aspirin to evaluate the platelet phenotype during pregnancy in patients.

Timeline

Start

2026-04-27

Primary completion

2027-08-01

Completion

2028-02-20

Drugs

Indications